Skip to main content
Erschienen in: World Journal of Urology 3/2020

13.05.2019 | Original Article

Photoselective vaporization of the prostate: study outcomes as a function of risk of bias, conflicts of interest, and industrial sponsorship

verfasst von: Marian S. Wettstein, Clinsy Pazhepurackel, Aline S. Neumann, Dixon T. S. Woon, Jaime O. Herrera-Caceres, Marko Kozomara, Cédric Poyet, Tullio Sulser, Girish S. Kulkarni, Thomas Hermanns

Erschienen in: World Journal of Urology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the outcomes of comparative studies on photoselective vaporization of the prostate (PVP) as a function of risk of bias (RoB), conflicts of interest (COI), and industrial sponsorship (IS).

Methods

We performed a systematic literature search for comparative studies on PVP [randomized controlled trials (RCTs) and non-randomized comparative studies (NRCSs)]. Study selection as well as comprehensive assessment of RoB, COIs, and IS were performed in duplicate. The identified studies were further rated by two independent board-certified urologists as either PVP-favourable or PVP-unfavourable. Descriptive statistics were performed among all identified studies and among the subgroups of studies rated as favourable and unfavourable, respectively.

Results

Sixty-five studies qualified for inclusion (25 RTCs and 40 NRCSs) of which 56 (86%) were rated favourable and 9 (14%) unfavourable. A majority of all studies mentioned the absence/presence of potential COIs (78%). In contrast, a sponsorship statement was only found in 29% of the investigations. Studies rated favourable demonstrated a higher percentage of COIs (39% versus 22%). IS was exclusively found among favourable studies. Furthermore, a serious or critical RoB was more often found in favourably rated NRCSs.

Conclusions

COIs and IS seem to be associated with favourable study outcomes in comparative studies on PVP. The transparency of the whole research process from study conception to the dissemination of the results has to be further improved to prevent a harmful effect of COIs and IS on the internal validity of studies.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bachmann A, Tubaro A, Barber N et al (2015) A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol 193:570–578CrossRef Bachmann A, Tubaro A, Barber N et al (2015) A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol 193:570–578CrossRef
2.
Zurück zum Zitat Thomas JA, Tubaro A, Barber N et al (2016) A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-years outcomes of the GOLIATH study. Eur Urol 69:94–102CrossRef Thomas JA, Tubaro A, Barber N et al (2016) A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-years outcomes of the GOLIATH study. Eur Urol 69:94–102CrossRef
3.
Zurück zum Zitat Bachmann A, Tubaro A, Barber N et al (2014) 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European multicentre randomised trial–the goliath study. Eur Urol 65:931–942CrossRef Bachmann A, Tubaro A, Barber N et al (2014) 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European multicentre randomised trial–the goliath study. Eur Urol 65:931–942CrossRef
4.
Zurück zum Zitat Chung DE, Wysock JS, Lee RK, Melamed SR, Kaplan SA, Te AE (2011) Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia. J Urol 186:977–981CrossRef Chung DE, Wysock JS, Lee RK, Melamed SR, Kaplan SA, Te AE (2011) Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia. J Urol 186:977–981CrossRef
5.
Zurück zum Zitat Thangasamy IA, Chalasani V, Bachmann A, Woo HH (2012) Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012. Eur Urol 62:315–323CrossRef Thangasamy IA, Chalasani V, Bachmann A, Woo HH (2012) Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012. Eur Urol 62:315–323CrossRef
6.
Zurück zum Zitat Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T (2005) High power (80 W) potassium-titanly-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 173:158–160CrossRef Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T (2005) High power (80 W) potassium-titanly-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 173:158–160CrossRef
7.
Zurück zum Zitat Friedman LS, Richter ED (2004) Relationship between conflicts of interest and research results. J Gen Intern Med 19:51–56CrossRef Friedman LS, Richter ED (2004) Relationship between conflicts of interest and research results. J Gen Intern Med 19:51–56CrossRef
8.
Zurück zum Zitat Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L (2018) Industry sponsorship and research outcome: systematic review with meta-analysis. Intensive Care Med 44:1603–1612CrossRef Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L (2018) Industry sponsorship and research outcome: systematic review with meta-analysis. Intensive Care Med 44:1603–1612CrossRef
11.
Zurück zum Zitat Sterne JA, Hernán MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. The BMJ 355:4919CrossRef Sterne JA, Hernán MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. The BMJ 355:4919CrossRef
12.
Zurück zum Zitat Schoenthaler M, Miernik A, Wilhelm K et al (2015) Level of evidence, sponsorship, conflict of interest policy and commercial impact of PubMed-listed clinical urolithiasis-related trials in 2014. BJU Int 117:787–792CrossRef Schoenthaler M, Miernik A, Wilhelm K et al (2015) Level of evidence, sponsorship, conflict of interest policy and commercial impact of PubMed-listed clinical urolithiasis-related trials in 2014. BJU Int 117:787–792CrossRef
13.
Zurück zum Zitat Boscolo-Berto R, Montisci M, Secco S et al (2016) Association between financial conflicts of interests and supportive opinions for erectile dysfunction treatment. J Bioethical Inq 13:439–448CrossRef Boscolo-Berto R, Montisci M, Secco S et al (2016) Association between financial conflicts of interests and supportive opinions for erectile dysfunction treatment. J Bioethical Inq 13:439–448CrossRef
14.
Zurück zum Zitat Khan S, Mermer M, Myers E, Sandhu H (2008) The roles of funding source, clinical trial outcome, and quality reporting in orthopedic surgery literature. Am J Orthop 3712:205–212 Khan S, Mermer M, Myers E, Sandhu H (2008) The roles of funding source, clinical trial outcome, and quality reporting in orthopedic surgery literature. Am J Orthop 3712:205–212
15.
Zurück zum Zitat Ezzet KA (2003) The prevalence of corporate funding in adult lower extremity research and its correlation with reported results. J Arthroplasty 18:138–145CrossRef Ezzet KA (2003) The prevalence of corporate funding in adult lower extremity research and its correlation with reported results. J Arthroplasty 18:138–145CrossRef
16.
Zurück zum Zitat Shah RV, Albert TJ, Bruegel-Sanchez V, Vaccaro AR, Hilibrand AS, Grauer JN (2005) Industry support and correlation to study outcome for papers published in spine. Spine 30:1099–1104CrossRef Shah RV, Albert TJ, Bruegel-Sanchez V, Vaccaro AR, Hilibrand AS, Grauer JN (2005) Industry support and correlation to study outcome for papers published in spine. Spine 30:1099–1104CrossRef
17.
Zurück zum Zitat Okike K, Kocher MS, Mehlman CT, Bhandari M (2007) Conflict of interest in orthopaedic research: an association between findings and funding in scientific presentations. JBJS 89:608–613CrossRef Okike K, Kocher MS, Mehlman CT, Bhandari M (2007) Conflict of interest in orthopaedic research: an association between findings and funding in scientific presentations. JBJS 89:608–613CrossRef
18.
Zurück zum Zitat Leopold SS, Warme WJ, Fritz Braunlich E, Shott S (2003) Association between funding source and study outcome in orthopaedic research. Clin Orthop Relat Res 415:293CrossRef Leopold SS, Warme WJ, Fritz Braunlich E, Shott S (2003) Association between funding source and study outcome in orthopaedic research. Clin Orthop Relat Res 415:293CrossRef
19.
Zurück zum Zitat Rochon PA, Gurwitz JH, Cheung C, Hayes JA, Chalmers TC (1994) Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA 272:108–113CrossRef Rochon PA, Gurwitz JH, Cheung C, Hayes JA, Chalmers TC (1994) Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA 272:108–113CrossRef
20.
Zurück zum Zitat Bero LA, Rennie D (1996) Influences on the quality of published drug studies. Int J Technol Assess Health Care 12:209–237CrossRef Bero LA, Rennie D (1996) Influences on the quality of published drug studies. Int J Technol Assess Health Care 12:209–237CrossRef
21.
Zurück zum Zitat Blumenthal D, Campbell EG, Anderson MS, Causino N, Louis K (1997) Withholding research results in academic life science: evidence from a national survey of faculty. JAMA 277:1224–1228CrossRef Blumenthal D, Campbell EG, Anderson MS, Causino N, Louis K (1997) Withholding research results in academic life science: evidence from a national survey of faculty. JAMA 277:1224–1228CrossRef
23.
Zurück zum Zitat Friedberg M, Saffran B, Stinson TJ, Nelson W, Bennett CL (1999) Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA 282:1453–1457CrossRef Friedberg M, Saffran B, Stinson TJ, Nelson W, Bennett CL (1999) Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA 282:1453–1457CrossRef
24.
Zurück zum Zitat Bodenheimer T (2000) Uneasy Alliance—clinical investigators and the pharmaceutical industry. N Engl J Med 342:1539–1544CrossRef Bodenheimer T (2000) Uneasy Alliance—clinical investigators and the pharmaceutical industry. N Engl J Med 342:1539–1544CrossRef
25.
Zurück zum Zitat Moher D, Hopewell S, Schulz KF et al (2012) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg 10:28–55CrossRef Moher D, Hopewell S, Schulz KF et al (2012) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg 10:28–55CrossRef
26.
Zurück zum Zitat Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. The Lancet 370:1453–1457CrossRef Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. The Lancet 370:1453–1457CrossRef
Metadaten
Titel
Photoselective vaporization of the prostate: study outcomes as a function of risk of bias, conflicts of interest, and industrial sponsorship
verfasst von
Marian S. Wettstein
Clinsy Pazhepurackel
Aline S. Neumann
Dixon T. S. Woon
Jaime O. Herrera-Caceres
Marko Kozomara
Cédric Poyet
Tullio Sulser
Girish S. Kulkarni
Thomas Hermanns
Publikationsdatum
13.05.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 3/2020
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-019-02799-3

Weitere Artikel der Ausgabe 3/2020

World Journal of Urology 3/2020 Zur Ausgabe

Neu im Fachgebiet Urologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Prostatakarzinom: EU initiiert neues Screeningkonzept

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Blasenkarzinom – Biomarker statt Zytologie?

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.